Tag: COVAXIN
Bharat Biotech’s COVAXIN Phase 3 results show interim clinical efficacy of...
Data from 25,800 participants that received the COVAXIN vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well-tolerated. It demonstrated 81% interim efficacy in preventing COVID-19 after the second dose....................
Bharat Biotech confirms deal with Brazil to supply 20 million doses...
It has signed an agreement for the delivery of COVAXIN during the second and third quarter of the year 2021.....................
Ukraine Health Minister visits Bharat Biotech vaccine plant at Hyderabad
The representatives from the Central Asian nation of 41 million people took a tour of the world-class Bio-Safety Level 3 manufacturing facility....................
BioAsia 2021 to honor Bharat Biotech with Genome Valley Excellence Award
Dr Krishna M. Ella, Mrs.Suchitra Ella and Dr Balram Bhargav are being honored in BioAsia 2021...............
Approval in India paves way for Bharat Biotech to take Covaxin...
Recently, Bharat Biotech has applied for regulatory approval to conduct clinical trials in Bangladesh and has applied for EUA in the Philippines.....................
Bharat Biotech signs deal with Ocugen to commercialize Covaxin in US...
Ocugen to receive an initial supply of COVAXIN™ doses from Bharat Biotech upon authorization from US regulatory authorities while it ramps up manufacturing in the US. The vaccine is currently in a fully enrolled Phase 3 clinical trial involving 25,800 patients...........
PM to launch pan India rollout of COVID-19 vaccination drive on...
Over 3000 sites across all States and UTs to be virtually connected during the launch. Around 100 beneficiaries to be vaccinated at each site on the inaugural day.......................
India’s Covid vaccine is a leap of science, says Vice President
Indigenous vaccine demonstrates benefits of Atmanirbhar Bharat to others, asserts Venkaiah Naidu while calling for the national resolve of 2020 to take the vaccine to the people this year...................
India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan
Dr Harsh Vardhan at the India-Portugal Technology Summit2020 “The next iteration of this collaboration will be to encourage new solutions based on cutting edge technologies such as Machine Learning and Artificial Intelligence”...................
COVID-19 vaccination: HMD to scale up production of auto-disable syringes to...
HMD has received an order from UNICEF to increase its supply of immunization AD syringes to the organization to around 300 million to build up a stockpile of around 140 million syringes for Covid-19 by the end of the year..................